Dose-dependent transcriptome changes by metal ores on a human acute lymphoblastic leukemia cell line

Abstract

The increased morbidity of childhood leukemia in Fallon, Nevada and Sierra Vista, Arizona has prompted great health concern. The main characteristic that these two towns share is the environmental pollution attributed to metal ore from abandoned mining operations. Consequently, we have investigated the transcriptome effects of metal ores from these endemic areas using a human T-cell acute lymphoblastic leukemia cell line (T-ALL). Metal ore from Fallon significantly increased cell growth after 24, 48 and 72 h of incubation at 1.5 mg/mL concentration, as measured by trypan-blue. Sierra Vista ore significantly increased cell growth with 0.15 and 1.5 mg/mL following 72 h of incubation. From human cDNA microarray, results indicate that in total, eight genes, mostly metallothionein (MT) genes, were up-regulated and 10 genes were down-regulated following treatment of the T-ALL cells with 0.15 and 1.5 mg/mL of metal ores at 72 h, in comparison with untreated cells. Twenty-eight metals of both ores were quantified and their presence may be associated with the cell growth rate and dose-dependent activation of transcriptomes in immature T-cells.

Keywords

gene microarray leukemia metallothionein metals transcriptomes tungsten

Get full access to this article

View all access options for this article.

References

Abdel-Mageed, A. and Agrawal, K. C. 1997: Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Therapy 4, 199-207.

Borghesi, L. A. , Youn, J. and Olson, E. A. et al. 1996: Interactions of metallothionein with murine lymphocytes: plasma membrane binding and proliferation. Toxicology 108, 129-140.

Chattopadhyay, G. , Lin, K. C. and Feitz, A. J. 2003: Household dust metal levels in the Sydney metropolitan area. Environmental Research 93, 301-307.

Cherian, M. G. 1993: Nuclear and cytoplasmic localization of metallothionein in human liver during development and in tumor cells. In Metallothionein III. Basel: Birkhauser Verlag, 175-178.

Cherian, M. G. and Apostolova, M. D. 2000: Nuclear localization of metallothionein during cell proliferation and differentiation. Cell Molecular Biology 46, 347-356.

De Boeck, M. , Lombaert, N. and De Backer, S. et al. 2003: In vitro genotoxic effects of different combinations of cobalt and metallic carbide particles. Mutagenesis 18, 177-186.

Durant, J. L. , Chen, J. and Hemond, H. F. et al. 1995: Elevated incidence of childhood leukemia in Woburn, Massachusetts: NIEHS Superfund Basic Research Program searches for causes. Environmental Health Perspectives 103, 93-98.

Foley, G. E. and Lazarus, H. 1967: The response in vitro, of continuous cultures of human lymphoblasts (CCRF-CEM cells) to chemotherapeutic agents. Biochemical Pharmacology 16, 659-674.

Garruto, R. M. 1991: Pacific paradigms of environmentally-induced neurological disorders: clinical, epidemiological and molecular perspectives. Neurotoxicology 12, 347-377.

10.

Infante-Rivard, C. , Olson, E. and Jacques, L. et al. 2001: Drinking water contaminants and childhood leukemia. Epidemiology 12, 13-19.

11.

Kagi, J. H. 1991: Overview of metallothionein. Methods in Enzymology 205, 613-626.

12.

Kasprzak, K. S. 1997: The oxidative damage hypothesis of the metal-induced genotoxicity and carcinogenesis. In Cytotoxic, mutagenic and carcinogenic potential of heavy metals related to human environment. New York: Kluwer Academic Publishers, 73-92.

13.

Lynes, M. A. , Garvey, J. S. and Lawrence, D. A. 1990: Extra-cellular metallothionein effects on lymphocyte activities. Molecular Immunology 27, 211-219.

14.

Margoshes, M. and Vallee, B. L. 1957: A cadmium protein from equine kidney cortex. Journal of the American Thermal Society 79, 4813-4814.

15.

Masironi, R. 1987: Geochemistry, soils and cardiovascular diseases. Experientia 43, 68-74.

16.

McCabe, Jr., M. J. , Singh, K. P. and Reiners, Jr., J. J. 2001: Low-level lead exposure in vitro stimulates the proliferation and expansion of alloantigen-reactive CD4 (high) T cells. Toxicology and Applied Pharmacology 177, 219-231.

17.

Mita, M. , Imura, N. and Kumazawa, Y. et al. 2002: Suppressed proliferative response of spleen T cells from metallothionein null mice. Microbiology and Immunology 46, 101-107.

18.

Rosen, J. F. 1995: Adverse health effects of lead at low exposure levels: trends in the management of childhood lead poisoning. Toxicology 97, 11-17.

19.

Sheppard, P. R. and Witten M. L. 2003: Dendrochemistry of urban trees in an environmental exposure analysis of childhood leukemia cluster areas. Abstracts, 2003 Fall Meeting of the American Geophysical Union, Washington DC.

20.

Studer, R. , Vogt, C. P. and Cavigelli, M. et al. 1997: Metallothionein accretion in human hepatic cells is linked to cellular proliferation. Biochemical Journal 328, 63-67.

21.

Tsangaris, G. T. and Tzortzatou-Stathopoulou, F. 1998: Metal-lothionein expression prevents apoptosis: a study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line. Anticancer Research 18, 2423-2433.

22.

Tseng, G. C. , Oh, M. K. and Rohlin, L. et al. 2001: Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects. Nucleic Acids Research 29, 2549-2557.

23.

Tsujikawa, K. , Sagawa, K. and Suzuki, N. et al. 1993: The relationship between nuclear localization of metallothionein and proliferation of rat hepatocytes. In Metallothionein III. Basel: Birkhauser Verlag, 427-442.

24.

Wong, S. S. , Sun, N. N. and Keith, I. et al. 2003: Tachykinin substance P signaling involved in diesel exhaust-induced bronchopulmonary neurogenic inflammation in rats. Archives of Toxicology 77, 638-650.

25.

Youn, J. and Lynes, M. A. 1999: Metallothionein-induced suppression of cytotoxic T lymphocyte function: an important immunoregulatory control. Toxicological Sciences 52, 199-208.